相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Dopamine D1 receptor availability is related to social behavior: A positron emission tomography study
Pontus Plaven-Sigray et al.
NEUROIMAGE (2014)
A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder
Cristina Cusin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Staging methods for treatment resistant depression. A systematic review
Henricus G. Ruhe et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Are Antipsychotics or Antidepressants Needed for Psychotic Depression? A Systematic Review and Meta-Analysis of Trials Comparing Antidepressant or Antipsychotic Monotherapy With Combination Treatment
Arusha Farahani et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
Hiroaki Hori et al.
SCIENTIFIC WORLD JOURNAL (2012)
Stress responses and the mesolimbic dopamine system: Social contexts and sex differences
Brian C. Trainor
HORMONES AND BEHAVIOR (2011)
Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation
Marie-Laure Paillere Martinot et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Striatal D2 receptor binding in 22q11 deletion syndrome: an [123I]IBZM SPECT study
E. Boot et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Systemic catechol-O-methyl transferase inhibition enables the D1 agonist radiotracer R-[11C]SKF 82957
Mikael Palner et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Pramipexole for stage 2 treatment-resistant major depression: An open study
Takeshi Inoue et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
J. Craig Nelson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder
Diego A. Pizzagalli et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
The Effect of Pramipexole on Mood and Motivational Symptoms in Parkinson's Disease: A Meta-analysis of Placebo-Controlled Studies
Albert F. G. Leentjens et al.
CLINICAL THERAPEUTICS (2009)
fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder
Moria J. Smoski et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
A Multidimensional Tool to Quantify Treatment Resistance in Depression: The Maudsley Staging Method
Abebaw Fekadu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Greater availability of dopamine transporters in patients with major depression - A dual-isotope SPECT study
Yen Kuang Yang et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
Relationship between regional brain metabolism, illness severity and age in depressed subjects
Jakub Z. Konarski et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
The role of dopamine in the pathophysiology of depression
Boadie W. Dunlop et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
Sara A. Corya et al.
DEPRESSION AND ANXIETY (2006)
Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation
K Nakayama et al.
BRAIN RESEARCH BULLETIN (2004)
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex
P Devoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Dopaminergic effects of facceine in the human striatum and thalamus
V Kaasinen et al.
NEUROREPORT (2004)
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine:: Differentiation from other atypical antipsychotics
J Tauscher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Clinical pharmacology of MAO inhibitors: Safety and future
M Yamada et al.
NEUROTOXICOLOGY (2004)
Pramipexole in treatment-resistant depression: a 16-week naturalistic study
L Lattanzi et al.
BIPOLAR DISORDERS (2002)
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
RV Parsey et al.
BIOLOGICAL PSYCHIATRY (2001)
Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression
T Izumi et al.
JOURNAL OF AFFECTIVE DISORDERS (2000)
Structure and function of dopamine receptors
D Vallone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
分享论文
